Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients

被引：0
|
作者：
Bichlien Nguyen
Pino G. Cusumano
Kenneth Deck
Deborah Kerlin
Agustin A. Garcia
Julie L. Barone
Edgardo Rivera
Katharine Yao
Femke A. de Snoo
Jeroen van den Akker
Lisette Stork-Sloots
Daniele Generali
机构：
[1] Long Beach Memorial Medical Center,Department of Medicine, Todd Cancer Institute
[2] CHC,Department of Surgical Oncology
[3] Saddleback Memorial Medical Center,Department of Surgical Oncology
[4] John Muir,Department of Surgery
[5] Keck School of Medicine of the University of Southern California,Division of Oncology
[6] Comprehensive Breast Care of San Diego and Sharp Memorial Hospital,Department of Surgery
[7] The Methodist Hospital/Weill Cornell University,Department of Medical Oncology
[8] North Shore University Health System,Department of Surgical Oncology
[9] Agendia N.V.,Department of Medical Oncology, U.O.M. Patologia Mammaria
[10] A.O. Istituti Ospitalieri di Cremona,Laboratorio di Oncologia Molecolare Senologica
来源：
Annals of Surgical Oncology | 2012年 / 19卷
关键词：
Estrogen Receptor; Luminal; Progesterone Receptor; Clinical Subtyping; Multigene Assay;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3257 / 3263
页数：6
相关论文
共 50 条
  • [1] Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients
    Bichlien Nguyen
    Cusumano, Pino G.
    Deck, Kenneth
    Kerlin, Deborah
    Garcia, Agustin A.
    Barone, Julie L.
    Rivera, Edgardo
    Yao, Katharine
    de Snoo, Femke A.
    van den Akker, Jeroen
    Stork-Sloots, Lisette
    Generali, Daniele
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (10) : 3257 - 3263
  • [2] MammaPrint and BluePrint in early breast cancer: Clinical implications of prognostic stratification and molecular subtyping
    Yao, K.
    Turk, M.
    Kaul, K.
    Wesseling, J.
    Stork-Sloots, L.
    de Snoo, F.
    Cristofanilli, M.
    [J]. CANCER RESEARCH, 2013, 73
  • [3] IMPACt trial: MammaPrint and BluePrint molecular subtyping guide treatment decisions in breast cancer
    Soliman, Hatem
    Rehmus, Esther
    Shah, Varsha
    Srkalovic, Gordan
    Mahtani, Reshma
    Levine, Ellis
    Mavromatis, Blanche
    Srinivasiah, Jayanthi
    Kassar, Mohamad
    Gabordi, Robert
    Yoder, Erin
    Qamar, Rubina
    Audeh, William
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [4] Comparison of Molecular Subtyping With BluePrint and MammaPrint to Local IHC/FISH-Based Subtype Classification in 133 US and EU Breast Cancer Patients
    Bichlien Nguyen
    Cusumano, Pino
    Deck, Ken
    Kerlin, Deborah
    Garcia, Augustin
    Barone, Julie
    Rivera, Edgardo
    Yao, Katherine
    Stork-Sloots, Lisette
    Generali, Daniele
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : 90 - 91
  • [5] Molecular subtyping using MammaPrint and BluePrint as an outcome predictor in US breast cancer (BC) patients.
    Yao, Katharine
    Turk, Mary
    Kaul, Karen
    Weaver, JoEllen
    De Snoo, Femke
    Stork-Sloots, Lisette
    Cristofanilli, Massimo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [6] Improving personalized management of primary breast cancer: Mammaprint® risk stratification and blueprint® molecular subtyping
    Mikkilineni, L.
    Austin, L. K.
    Limentani, K.
    Jaslow, R. J.
    Avery, T. P.
    Palazzo, J.
    Cristofanilli, M.
    [J]. CANCER RESEARCH, 2016, 76
  • [7] Comparison of Molecular Subtyping with BluePrint and MammaPrint to Local IHC/FISH Based Subtype Classification According to St Gallen 2011 in 133 Breast Cancer Patients
    Generali, D.
    Nguyen, B.
    Deck, K.
    Kerlin, D.
    Garcia, A.
    Barone, J.
    Rivera, E.
    Yao, K.
    Stork-Sloots, L.
    Cusumano, P.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S143 - S143
  • [8] Molecular subtyping using MammaPrint and BluePrint as an outcome predictor in 180 US breast cancer (BC) patients.
    Stork-Sloots, Lisette
    Yao, Katharine
    Turk, Mary
    Kaul, Karen
    Weaver, JoEllen
    De Snoo, Femke
    Cristofanilli, Massimo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Comparison of MammaPrint, BluePrint, and TargetPrint with clinical parameters in patients with breast cancer: Findings from a prospective United States cohort
    Nguyen, B.
    Deck, K. B.
    Sinha, R.
    Kerlin, D.
    Barone, J.
    Rivera, E.
    Garcia, A.
    Yao, K.
    Stork-Sloots, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [10] Comparison of MammaPrint, BluePrint, and TargetPrint with Clinical Parameters in Patients with Breast Cancer: Findings from a Prospective United States Cohort.
    Nguyen, B.
    Sinha, R.
    Kerlin, D.
    Barone, J.
    Garcia, A.
    Yao, K.
    Riyera, E.
    Stork-Sloots, L.
    Deck, K.
    [J]. CANCER RESEARCH, 2011, 71
12345